| Caitlin J Armijo, | |
|
Msc 09 5030, 1 University Of New Mexico, Albuquerque, NM 87131-0001 | |
| (505) 272-2223 | |
| (505) 272-4639 |
| Full Name | Caitlin J Armijo |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 8 Years |
| Location | Msc 09 5030, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285098657 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD2020-0330 (New Mexico) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of New Mexico Medical Group | 4981795267 | 1002 |
News Archive
AMAG Pharmaceuticals, Inc. today announced that three abstracts have been accepted for presentation at the American Society of Nephrology (ASN) Renal Week meeting being held October 27-November 1, 2009 in San Diego, CA.
OSI Pharmaceuticals, Inc. announced today that its 2% Convertible Senior Subordinated Notes due 2025 are convertible at the option of the holders and will remain convertible at least through July 19, 2010, as provided for in the Indenture governing the notes.
Genzyme announced today that it has filed a lawsuit in the District Court of Tel Aviv alleging that Transkaryotic Therapies Inc. has infringed Genzyme's Israeli patent No. 100,715, which covers certain cell culture processes involved in the manufacture of glucocerebrosidase.
Researchers have determined the structure of a key genetic mechanism at work in bacteria, including some that are deadly to humans, in an important step toward the design of a new class of antibiotics, according to an accelerated publication that appeared online today as a "paper of the week" in the Journal of Biological Chemistry.
› Verified 9 days ago
| Entity Name | Unm Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831218627 PECOS PAC ID: 4981795267 Enrollment ID: O20070801000589 |
News Archive
AMAG Pharmaceuticals, Inc. today announced that three abstracts have been accepted for presentation at the American Society of Nephrology (ASN) Renal Week meeting being held October 27-November 1, 2009 in San Diego, CA.
OSI Pharmaceuticals, Inc. announced today that its 2% Convertible Senior Subordinated Notes due 2025 are convertible at the option of the holders and will remain convertible at least through July 19, 2010, as provided for in the Indenture governing the notes.
Genzyme announced today that it has filed a lawsuit in the District Court of Tel Aviv alleging that Transkaryotic Therapies Inc. has infringed Genzyme's Israeli patent No. 100,715, which covers certain cell culture processes involved in the manufacture of glucocerebrosidase.
Researchers have determined the structure of a key genetic mechanism at work in bacteria, including some that are deadly to humans, in an important step toward the design of a new class of antibiotics, according to an accelerated publication that appeared online today as a "paper of the week" in the Journal of Biological Chemistry.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Caitlin J Armijo, Msc 09 5030, 1 University Of New Mexico, Albuquerque, NM 87131-0001 Ph: () - | Caitlin J Armijo, Msc 09 5030, 1 University Of New Mexico, Albuquerque, NM 87131-0001 Ph: (505) 272-2223 |
News Archive
AMAG Pharmaceuticals, Inc. today announced that three abstracts have been accepted for presentation at the American Society of Nephrology (ASN) Renal Week meeting being held October 27-November 1, 2009 in San Diego, CA.
OSI Pharmaceuticals, Inc. announced today that its 2% Convertible Senior Subordinated Notes due 2025 are convertible at the option of the holders and will remain convertible at least through July 19, 2010, as provided for in the Indenture governing the notes.
Genzyme announced today that it has filed a lawsuit in the District Court of Tel Aviv alleging that Transkaryotic Therapies Inc. has infringed Genzyme's Israeli patent No. 100,715, which covers certain cell culture processes involved in the manufacture of glucocerebrosidase.
Researchers have determined the structure of a key genetic mechanism at work in bacteria, including some that are deadly to humans, in an important step toward the design of a new class of antibiotics, according to an accelerated publication that appeared online today as a "paper of the week" in the Journal of Biological Chemistry.
› Verified 9 days ago
Melissa A Merhege, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 500 Walter St Ne Ste 213, Albuquerque, NM 87102 Phone: 505-727-7177 Fax: 505-727-3778 | |
Dr. Anju C Jaiswal, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Children Psychiatric Hospital, 1001 Yale Blvd., Albuquerque, NM 87131 Phone: 505-272-2890 | |
George Edwin Davis, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1002 Idlewilde Ln Se, Albuquerque, NM 87108 Phone: 505-270-7479 | |
Shannon Stromberg, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Unm Psychiatric Ctr, 2600 Marble Ne, Albuquerque, NM 87131 Phone: 505-272-2800 Fax: 505-272-8692 | |
Liz-beth Porter, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Unm Hospital Psychiatry, 2211 Lomas Blvd Ne, Albuquerque, NM 87131 Phone: 505-272-6225 | |
Mr. Ronald Lee Romanik, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 7520 Montgomery Blvd Ne, Suite D12, Albuquerque, NM 87109 Phone: 505-323-6969 Fax: 505-323-9696 | |
Dr. Justin F Beatty, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Msc 09 5030 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-2223 |